Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.

Dorkin HL, Staab D, Operschall E, Alder J, Criollo M.

BMJ Open Respir Res. 2015 Dec 2;2(1):e000100. doi: 10.1136/bmjresp-2015-000100. eCollection 2015.

2.

Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.

Gaggar A, Chen J, Chmiel JF, Dorkin HL, Flume PA, Griffin R, Nichols D, Donaldson SH.

J Cyst Fibros. 2016 Mar;15(2):227-33. doi: 10.1016/j.jcf.2015.07.009. Epub 2015 Aug 28.

3.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, OrdoƱez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW.

Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.

4.

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.

Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM.

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S255-61. doi: 10.1007/s10545-010-9117-3. Epub 2010 Jun 3.

PMID:
20521170
5.

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, Clancy JP, Spencer LT, Pilewski J, Waltz DA, Dorkin HL, Ferkol T, Pian M, Ramsey B, Carter BJ, Martin DB, Heald AE.

Hum Gene Ther. 2007 Aug;18(8):726-32.

PMID:
17685853
6.

Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.

O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R.

Pediatrics. 2006 Sep;118(3):1260-5.

PMID:
16951024
7.

Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.

Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB.

J Pediatr. 2005 Sep;147(3 Suppl):S98-100.

PMID:
16202793
8.

Challenges in implementing a successful newborn cystic fibrosis screening program.

Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB.

J Pediatr. 2005 Sep;147(3 Suppl):S89-93. Review.

PMID:
16202791
9.

Sweat testing infants detected by cystic fibrosis newborn screening.

Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP.

J Pediatr. 2005 Sep;147(3 Suppl):S69-72.

PMID:
16202787
10.

Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition.

Shnayderman M, Mansfield B, Yip P, Clark HA, Krebs MD, Cohen SJ, Zeskind JE, Ryan ET, Dorkin HL, Callahan MV, Stair TO, Gelfand JA, Gill CJ, Hitt B, Davis CE.

Anal Chem. 2005 Sep 15;77(18):5930-7.

PMID:
16159124
11.

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.

Pediatrics. 2004 Jun;113(6):1573-81.

PMID:
15173476
12.

Practice of pediatric pulmonology: results of the Future of Pediatric Education Project (FOPE)

Redding GJ, Cloutier MM, Dorkin HL, Brotherton SE, Mulvey HJ.

Pediatr Pulmonol. 2000 Sep;30(3):190-7.

PMID:
10973036
13.

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ.

Pediatr Infect Dis J. 1999 Mar;18(3):223-31. Review. No abstract available.

PMID:
10093942
14.

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV, Wilmott RW, Wohl ME, Fuchs HJ, Christiansen DH, Smith AL.

J Pediatr. 1997 Jul;131(1 Pt 1):118-24.

PMID:
9255202
15.

Interpretation of respiratory input impedance in healthy infants.

Jackson AC, Neff KM, Dorkin HL, Lutchen KR.

Pediatr Pulmonol. 1996 Dec;22(6):364-75.

PMID:
9016470
16.

Elastin and collagen degradation products in urine of patients with cystic fibrosis.

Stone PJ, Konstan MW, Berger M, Dorkin HL, Franzblau C, Snider GL.

Am J Respir Crit Care Med. 1995 Jul;152(1):157-62.

PMID:
7599816
17.

Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines.

Grubman SA, Fang SL, Mulberg AE, Perrone RD, Rogers LC, Lee DW, Armentano D, Murray SL, Dorkin HL, Cheng SH, et al.

Gastroenterology. 1995 Feb;108(2):584-92.

PMID:
7530672
18.

Consensus conference: practical applications of Pulmozyme. September 22, 1993.

Ramsey BW, Dorkin HL.

Pediatr Pulmonol. 1994 Jun;17(6):404-8. Review. No abstract available.

PMID:
8090614
19.

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV, et al.

Am Rev Respir Dis. 1993 Jul;148(1):145-51.

PMID:
8317790
20.

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, et al.

N Engl J Med. 1993 Jun 17;328(24):1740-6.

21.

Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.

Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW.

Hum Mol Genet. 1993 Feb;2(2):159-63.

PMID:
7684637
22.

Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines.

Jefferson DM, Valentich JD, Marini FC, Grubman SA, Iannuzzi MC, Dorkin HL, Li M, Klinger KW, Welsh MJ.

Am J Physiol. 1990 Dec;259(6 Pt 1):L496-505.

PMID:
1701980
23.

Respiratory impedance and multibreath N2 washout in healthy, asthmatic, and cystic fibrosis subjects.

Lutchen KR, Habib RH, Dorkin HL, Wall MA.

J Appl Physiol (1985). 1990 May;68(5):2139-49.

PMID:
2361915
24.

Density dependence of respiratory system impedances between 5 and 320 Hz in humans.

Jackson AC, Giurdanella CA, Dorkin HL.

J Appl Physiol (1985). 1989 Dec;67(6):2323-30.

PMID:
2606839
25.

Human respiratory input impedance from 4 to 200 Hz: physiological and modeling considerations.

Dorkin HL, Lutchen KR, Jackson AC.

J Appl Physiol (1985). 1988 Feb;64(2):823-31.

PMID:
3372439
26.

Inverse modeling of dog airway and respiratory system impedances.

Jackson AC, Lutchen KR, Dorkin HL.

J Appl Physiol (1985). 1987 Jun;62(6):2273-82.

PMID:
3610923
27.

Respiratory system impedance from 4 to 40 Hz in paralyzed intubated infants with respiratory disease.

Dorkin HL, Stark AR, Werthammer JW, Strieder DJ, Fredberg JJ, Frantz ID 3rd.

J Clin Invest. 1983 Sep;72(3):903-10.

28.

CT appearance of the liver in a patient with biliary cirrhosis and cystic fibrosis.

Schwartz AM, Dorkin HL, Carter BL.

J Comput Assist Tomogr. 1983 Jun;7(3):530-3. No abstract available.

PMID:
6841724
29.

Interaction of oscillatory and unidirectional flows in straight tubes and an airway cast.

Dorkin HL, Jackson AC, Strieder DJ, Dawson SV.

J Appl Physiol Respir Environ Exerc Physiol. 1982 Apr;52(4):1097-1105.

PMID:
7085411
30.

Airway area by acoustic reflections measured at the mouth.

Fredberg JJ, Wohl ME, Glass GM, Dorkin HL.

J Appl Physiol Respir Environ Exerc Physiol. 1980 May;48(5):749-58.

PMID:
7451282
31.

Studies on human erythrocyte inorganic pyrophosphatase.

Fisher RA, Turner BM, Dorkin HL, Harris H.

Ann Hum Genet. 1974 Jan;37(3):341-53. No abstract available.

PMID:
4130389

Supplemental Content

Loading ...
Support Center